Efficacy and Safety of FGF21 Versus Semaglutide in the Management of Metabolic-Associated Steatotic Liver Disease: A Network Meta-analysis.
| Autor: | Ayesh H; Endocrinology Division, Deaconess Clinic, Evansville, IN., Olajide OB; Department of Medicine, Division of Diabetes, Endocrinology, and Metabolism, Vanderbilt University Medical Center, Nashville, TN. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | American journal of therapeutics [Am J Ther] 2024 Sep 19. Date of Electronic Publication: 2024 Sep 19. |
| DOI: | 10.1097/MJT.0000000000001814 |
| Abstrakt: | Competing Interests: The authors have no conflicts of interest to declare. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|